Table 3.
Malaria cases | Uncomplicated cases | Complicated cases | Healthy controls | P-value* | |
---|---|---|---|---|---|
n = 28 | n = 21 | n = 7 | n = 26 | ||
NT-proBNP, ng/ml (± SD) | 139.3 (± 146.6) | 117.7 (± 140.3) | 231.1 (± 156.2) | 60.4 (± 48.2) | 0.07 |
CK-MB, ng/ml (± SD) | 21.5 (± 36.9) | 24.0 (± 40.7) | 10.8 (± 6.1) | 12.1 (± 10.3) | 0.08 |
Myoglobin, mg/l (± SD) | 43.6 (± 12.5) | 42.9 (± 12.0) | 45.4 (± 15.0) | 27.8 (± 15.0) | < 0.001 |
TnT, ng/ml (± SD) | < 0.1 (na) | < 0.1 (na) | < 0.1 (na) | < 0.1 (na) | ns |
H-FABP, ng/ml (± SD) | 1.9 (± 1.1) | 1.7 (± 1.0) | 2.7 (± 1.0) | 1.1 (± 1.6) | < 0.01 |
NT-proBNP = N-terminal pro-brain natriuretic peptide; CK-MB = creatine kinase-muscle brain; TnT = troponin T; H-FABP = heart-type fatty acid-binding protein
*comparison between malaria cases (all) and healthy controls (by Mann-Whitney U-test)